Mu Dali, Lin Yan, Zhang Xiaoyu, Li Zhengyao
Department of Aesthetic and Reconstructive Breast Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 33 Badachu Road, Shijingshan District, Beijing, 100144, People's Republic of China.
Aesthetic Plast Surg. 2025 Feb;49(3):727-732. doi: 10.1007/s00266-024-04346-x. Epub 2024 Sep 3.
Secondary reduction mammaplasty poses challenges.
This article delves into the reasons and complaints regarding secondary repair following double-ring method and outlines the principle and logic of utilizing vertical incision for repair.
A retrospective analysis of patients who underwent secondary reduction mammaplasty in our hospital was conducted. The analysis included baseline demographic data, reasons for consultation, surgical records, and postoperative outcomes.
Thirty-five patients (70 breasts) underwent secondary reduction mammaplasty. The mean time between the primary reduction mammaplasty and second procedure was 2.99 years (range, 0.5-15years). The mean weights were 210.49g (range, 42-558g) and 207.91g (range, 6-560g) for left and right mastectomies, respectively. Reasons for secondary reduction mammaplasty include poor shape (flat breasts and pseudoptosis), widened incision scar, persistent macromastia, and bilateral asymmetry.
The superior and superomedial vertical techniques are safe, effective, and satisfactory in secondary reduction mammaplasty.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
二次乳房缩小成形术存在挑战。
本文深入探讨双环法二次修复的原因及相关问题，并概述采用垂直切口进行修复的原则和逻辑。
对我院接受二次乳房缩小成形术的患者进行回顾性分析。分析内容包括基线人口统计学数据、咨询原因、手术记录及术后结果。
35例患者（70侧乳房）接受了二次乳房缩小成形术。初次乳房缩小成形术与二次手术之间的平均时间为2.99年（范围0.5 - 15年）。左、右乳房切除术的平均重量分别为210.49g（范围42 - 558g）和207.91g（范围6 - 560g）。二次乳房缩小成形术的原因包括外形不佳（乳房扁平及假性下垂）、切口瘢痕增宽、巨乳症持续存在及双侧不对称。
在二次乳房缩小成形术中，上半部分及上内侧垂直技术安全、有效且效果令人满意。
证据等级IV：本刊要求作者为每篇文章指定证据等级。有关这些循证医学评级的完整描述，请参阅目录或在线作者指南www.springer.com/00266 。
